Loading...
Pembrolizumab in performance status 2 patients with non-small cell lung cancer (NSCLC): results of the PePS2 trial
Middleton, G Brock, K Summers, Yvonne J Connibear, J Shah, R Ottensmeier, C Shaw, P Ming-Lee, S Popat, S Barrie, C
Middleton, G
Brock, K
Summers, Yvonne J
Connibear, J
Shah, R
Ottensmeier, C
Shaw, P
Ming-Lee, S
Popat, S
Barrie, C
Citations
Altmetric:
Abstract
Description
Date
2018
Publisher
Collections
Files
Loading...
From UNPAYWALL
Adobe PDF, 91.23 KB
Keywords
Type
Meetings and Proceedings
Citation
Middleton G, Brock K, Summers Y, Connibear J, Shah R, Ottensmeier C, et al. 1384PD Pembrolizumab in performance status 2 patients with non-small cell lung cancer (NSCLC): results of the PePS2 trial. Ann Oncol. 2018;29(suppl_8):497.